The clinical use of staging bone scan in patients with breast carcinoma: Reevaluation by the 2003 American Joint Committee on Cancer staging system

Cancer

Volumn 104, Issue 3, 2005, Pages 499-503

  Lee, Jeong Eon ^a   Park, Sung Shin ^b   Han, Wonshik ^a   Kim, Seok Won ^a   Shin, Hyuk Jai ^a   Choe, Kuk Jin ^a   Oh, Seung Keun ^a   Youn, Yeo Kyu ^a   Noh, Dong Young ^a   Kim, Sung Won ^c  

^a Seoul National University   (South Korea)

^b Dongguk University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Bone metastasis; Bone scan; Breast carcinoma; Staging

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; SURVIVAL RATE;

EID: 22544458457     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21200     Document Type: Article

References (19)

1. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27:165-176.
2. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61-66.
3. Norum J, Andreassen T. Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective? Anticancer Res. 2000;20:2193-2196.
4. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994;271:1593-1597.
5. Curigliano G, Ferretti G, Colleoni M, et al. Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms. Ann Oncol. 2001;12:724-725.
6. Koizumi M, Yoshimoto M, Kasumi F, Ogata E. What do breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol. 2001;31:263-269.
7. Myers RE, Johnston M, Pritchard K, Levine M, Oliver T. Baseline staging tests in primary breast cancer: a practice guideline. Can Med Assoc. J 2001;164:1439-1444.
8. Ravaioli A, Pasini G, Polselli A, et al. Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat. 2002;72:53-60.
9. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U, Fink D. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet. 2003;269:9-12.
10. Ravaioli A, Tassinari D, Pasini G, et al. Staging of breast cancer: what standards should be used in research and clinical practice? Ann Oncol. 1998;9:1173-1177.
11. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
12. Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21:3244-3248.
13. Joseph E, Hyacinthe M, Lyman GH, et al. Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol. 1998;5:522-528.
14. Jubelirer SJ. Surveillance testing in patients with early stage breast cancer: a review. W V Med J. 1998;94:14-17.
15. Samant R, Ganguly P. Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg. 1999;134:551-553; discussion 554.
16. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080-1082.
17. Maffioli L, Florimonte L, Pagani L, Butti I, Roca I. Current role of bone scan with phosphonates in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging. 2004;31 Suppl 1:5143-148.
18. Tassinari D, Sartori S, Ravaioli A. Staging of breast cancer. Is the evidence so evident? Ann Oncol. 2001;12:1653.
19. Kopans DB, Monsees B, Feig SA. Screening for cancer: when is it valid?-lessons from the mammography experience [letter]. Radiology. 2003;229:319-327.